Dr Timothy Francis-mooney Doyle, DO | |
833 S Governors Ave, Dover, DE 19904-4158 | |
(302) 674-1121 | |
(302) 674-3891 |
Full Name | Dr Timothy Francis-mooney Doyle |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 19 Years |
Location | 833 S Governors Ave, Dover, Delaware |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700017902 | NPI | - | NPPES |
1700017902 | Medicaid | DE |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Delaware Eye Care Center Pa | 6002868767 | 17 |
News Archive
A means of reprogramming a flawed immune response into an efficient anti-tumoral one was brought to light by the results of a translational trial relating to breast cancer. Thanks to the innovative combination of mathematical modelisation and experimentation, only 20 tests were necessary, whereas traditional experimentation would have required 596 tests to obtain the same results.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
President Donald Trump has railed against the high price of prescription drugs and famously bemoaned how pharmaceutical companies are "getting away with murder." Yet, many Americans aren't seeing a change in what they pay out-of-pocket.
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
› Verified 8 days ago
Entity Name | Delaware Eye Care Center Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932174505 PECOS PAC ID: 6002868767 Enrollment ID: O20050210000903 |
News Archive
A means of reprogramming a flawed immune response into an efficient anti-tumoral one was brought to light by the results of a translational trial relating to breast cancer. Thanks to the innovative combination of mathematical modelisation and experimentation, only 20 tests were necessary, whereas traditional experimentation would have required 596 tests to obtain the same results.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
President Donald Trump has railed against the high price of prescription drugs and famously bemoaned how pharmaceutical companies are "getting away with murder." Yet, many Americans aren't seeing a change in what they pay out-of-pocket.
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Timothy Francis-mooney Doyle, DO 833 S Governors Ave, Dover, DE 19904-4158 Ph: (302) 674-1121 | Dr Timothy Francis-mooney Doyle, DO 833 S Governors Ave, Dover, DE 19904-4158 Ph: (302) 674-1121 |
News Archive
A means of reprogramming a flawed immune response into an efficient anti-tumoral one was brought to light by the results of a translational trial relating to breast cancer. Thanks to the innovative combination of mathematical modelisation and experimentation, only 20 tests were necessary, whereas traditional experimentation would have required 596 tests to obtain the same results.
Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.
President Donald Trump has railed against the high price of prescription drugs and famously bemoaned how pharmaceutical companies are "getting away with murder." Yet, many Americans aren't seeing a change in what they pay out-of-pocket.
Among older patients with diabetes, those who are overweight or obese may have a lower risk of dying prematurely than their normal weight counterparts. The finding comes from a recent analysis of published studies.
› Verified 8 days ago
Dr. Andreas Rauer, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 16 Old Rudnick Ln, Dover, DE 19901 Phone: 302-734-1760 Fax: 302-734-1720 | |
Gary I Markowitz, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 833 S Governors Ave, Dover, DE 19904 Phone: 302-674-1121 Fax: 302-674-3891 | |
Dr. David Michael Creech, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St Ste 130, Dover, DE 19904 Phone: 302-678-1700 Fax: 302-678-2330 | |
Dr. Bryan D. Seiff, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St Ste 370, Dover, DE 19904 Phone: 302-678-3443 Fax: 302-678-9775 | |
Neha Kumar, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 833 S Governors Ave, Dover, DE 19904 Phone: 800-900-2020 Fax: 302-269-3503 |